Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001047469-05-022088
Filing Date
2005-08-26
Accepted
2005-08-26 16:41:01
Documents
5
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A a2161181z10-ka.htm 10-K/A 1553773
2 EXHIBIT 23.1 a2161181zex-23_1.htm EX-23.1 2620
3 EXHIBIT 31.1 a2161181zex-31_1.htm EX-31.1 6170
4 EXHIBIT 31.2 a2161181zex-31_2.htm EX-31.2 6170
5 EXHIBIT 32.1 a2161181zex-32_1.htm EX-32.1 4163
  Complete submission text file 0001047469-05-022088.txt   1574340
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16789 | Film No.: 051052473
SIC: 2835 In Vitro & In Vivo Diagnostic Substances